Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Interest Expenses (2018 - 2023)

Health Catalyst's Interest Expenses history spans 6 years, with the latest figure at -$2.6 million for Q4 2023.

  • For Q4 2023, Interest Expenses fell 155.97% year-over-year to -$2.6 million; the TTM value through Sep 2024 reached -$2.6 million, up 65.18%, while the annual FY2023 figure was -$9.1 million, 642.67% down from the prior year.
  • Interest Expenses reached -$2.6 million in Q4 2023 per HCAT's latest filing, roughly flat from -$2.6 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4.4 million in Q3 2021 to a low of -$2.6 million in Q4 2023.
  • Average Interest Expenses over 5 years is $1.2 million, with a median of $1.1 million recorded in 2019.
  • Peak YoY movement for Interest Expenses: surged 722.63% in 2020, then tumbled 1735.92% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $495000.0 in 2019, then soared by 722.63% to $4.1 million in 2020, then grew by 7.47% to $4.4 million in 2021, then tumbled by 123.35% to -$1.0 million in 2022, then plummeted by 155.97% to -$2.6 million in 2023.
  • Per Business Quant, the three most recent readings for HCAT's Interest Expenses are -$2.6 million (Q4 2023), -$2.6 million (Q3 2023), and -$2.1 million (Q2 2023).